Incidence of open neural tube defects in Nova Scotia after folic acid fortification
- PMID: 12186168
- PMCID: PMC117468
Incidence of open neural tube defects in Nova Scotia after folic acid fortification
Abstract
Background: With the goal of preventing open neural tube defects (NTDs), recommendations for folic acid supplementation before conception were introduced in Canada in 1994, and by November 1998 Canadian grain products were being fortified with folic acid. We wished to determine whether the annual incidence of open NTDs in Nova Scotia, including those in stillbirths and terminated pregnancies, changed after the introduction of either folic acid supplementation or fortification.
Methods: For the 10-year period from Jan. 1, 1991, to Dec. 31, 2000, we retrospectively extracted the total number of births in Nova Scotia and the number of live births and stillbirths with open NTDs from the Nova Scotia Atlee Perinatal Database as well as the number of terminated pregnancies affected by NTDs from the Fetal Anomaly Database. We determined the total annual incidence of all open NTDs, and of the subgroups spina bifida and anencephaly, per 1000 births in the province during the periods before (1991-1994) and after (1995-1998) folic acid supplementation initiatives were begun but before folic acid fortification of grain products was implemented, and during the periods before (1991-1997) and after (1998-2000) fortification.
Results: In the period after supplementation initiatives were begun but before fortification was implemented, the incidence of open NTDs did not change significantly: the mean annual rate was 2.55 per 1000 births during 1991-1994 and 2.61 per 1000 births during 1995-1997 (relative risk [RR] 1.02, 95% confidence interval [CI] 0.77-1.35). After the fortification was implemented the incidence of open NTDs decreased by more than 50%: the mean annual rate was 2.58 per 1000 births during 1991-1997 and 1.17 per 1000 births during 1998-2000 (relative risk 0.46, 95% CI 0.32-0.66).
Interpretation: The recommendations for folic acid supplementation alone did not appear to succeed in reducing the incidence of open NTDs in Nova Scotia, whereas the fortification of grain products with folic acid did result in a significant reduction in the incidence.
Comment in
-
Neural tube defects and periconceptional folic acid.CMAJ. 2002 Aug 6;167(3):255-6. CMAJ. 2002. PMID: 12186171 Free PMC article. No abstract available.
-
Folic acid fortification: time for a concentrated effort.CMAJ. 2002 Oct 15;167(8):848; author reply 848-9. CMAJ. 2002. PMID: 12406938 Free PMC article. No abstract available.
References
-
- Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural tube defects. N Engl J Med 1999;341(20):1509-19. - PubMed
-
- Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects [review]. Cochrane Database Syst Rev 2000;(2):CD001056. - PubMed
-
- MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Vitamin Study. Lancet 1991;338:131-7. - PubMed
-
- Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5. - PubMed
-
- Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 1992;41(RR-14):1-7. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials